Charles Schwab’s Morphic Holding, Inc. Common Stock MORF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-327,844
| Closed | -$11.2M | – | 3638 |
|
|
2024
Q2 | $11.2M | Buy |
327,844
+1,147
| +0.4% | +$34K | ﹤0.01% | 1994 |
|
|
2024
Q1 | $11.5M | Buy |
326,697
+7,247
| +2% | +$243K | ﹤0.01% | 1920 |
|
|
2023
Q4 | $9.23M | Buy |
319,450
+15,174
| +5% | +$361K | ﹤0.01% | 2026 |
|
|
2023
Q3 | $6.97M | Buy |
304,276
+37,264
| +14% | +$1.96M | ﹤0.01% | 2106 |
|
|
2023
Q2 | $15.3M | Buy |
267,012
+55,642
| +26% | +$2.91M | ﹤0.01% | 1677 |
|
|
2023
Q1 | $7.96M | Buy |
211,370
+212
| +0.1% | +$7.81K | ﹤0.01% | 1982 |
|
|
2022
Q4 | $5.65M | Buy |
211,158
+4,534
| +2% | +$124K | ﹤0.01% | 2155 |
|
|
2022
Q3 | $5.85M | Buy |
206,624
+14,194
| +7% | +$396K | ﹤0.01% | 2131 |
|
|
2022
Q2 | $4.18M | Buy |
192,430
+13,326
| +7% | +$372K | ﹤0.01% | 2263 |
|
|
2022
Q1 | $7.19M | Buy |
179,104
+4,647
| +3% | +$194K | ﹤0.01% | 2107 |
|
|
2021
Q4 | $8.27M | Buy |
174,457
+6,240
| +4% | +$335K | ﹤0.01% | 2098 |
|
|
2021
Q3 | $9.53M | Buy |
168,217
+54,061
| +47% | +$3.27M | ﹤0.01% | 2040 |
|
|
2021
Q2 | $6.55M | Buy |
114,156
+15,190
| +15% | +$836K | ﹤0.01% | 2219 |
|
|
2021
Q1 | $6.26M | Buy |
98,966
+22,655
| +30% | +$1.04M | ﹤0.01% | 2187 |
|
|
2020
Q4 | $2.56M | Buy |
76,311
+3,238
| +4% | +$95.7K | ﹤0.01% | 2529 |
|
|
2020
Q3 | $2M | Buy |
73,073
+14,752
| +25% | +$387K | ﹤0.01% | 2492 |
|
|
2020
Q2 | $1.58M | Buy |
58,321
+12,500
| +27% | +$234K | ﹤0.01% | 2496 |
|
|
2020
Q1 | $673K | Buy |
45,821
+12,762
| +39% | +$214K | ﹤0.01% | 2605 |
|
|
2019
Q4 | $568K | Buy |
33,059
+385
| +1% | +$6K | ﹤0.01% | 2775 |
|
|
2019
Q3 | $592K | Buy |
+32,674
| New | +$685K | ﹤0.01% | 2735 |
|
Other funds holding MORF
Charles Schwab's MORF Position: Q3 2024 in Review
Charles Schwab sold out of Morphic Holding, Inc. Common Stock (MORF) in Q3 2024, closing a stake of 327,844 shares — an estimated $11.2M sold.
Charles Schwab first reported a position in MORF in Q3 2019 and held it in 20 quarters. The position peaked at $15.3M in Q2 2023. 2 funds tracked by Wall St. Rank hold MORF as of Q3 2024.
- Charles Schwab reported no remaining Morphic Holding, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
- Charles Schwab sold 327,844 Morphic Holding, Inc. Common Stock shares in Q3 2024, an estimated $11.2M.
- Charles Schwab first reported a position in Morphic Holding, Inc. Common Stock in Q3 2019 and held it in 20 quarters.
- Charles Schwab's Morphic Holding, Inc. Common Stock position peaked at $15.3M in Q2 2023.
- 2 funds tracked by Wall St. Rank held Morphic Holding, Inc. Common Stock as of Q3 2024.
Based on Charles Schwab's 13F filing for Q3 2024, filed 12 Nov 2024.